Latest Brisbane News

Arovella Therapeutics has released a second clinical batch of its off-the-shelf CAR-iNKT therapy ALA-101, with material expected to support dose escalation and the start of dose expansion in blood cancers. The company is also adding hospital sites ahead of anticipated first-patient dosing in late October.

Data#3 expects first-half FY27 profit before tax to rise more than 40% year on year, with gross profit also tracking more than 15% higher. The stronger result will be helped by large transactions, infrastructure activity and a temporary interest income boost, but the company expects earnings to be weighted toward the first half.

Thrive Tribe Technologies has repositioned WooBoard and REFFIND towards defence and workforce software, but its FY26 annual report flags a material uncertainty over the company’s ability to continue as a going concern. The pivot follows a $3.66 million loss, $2.57 million operating cash outflow and another $1 million placement after year-end.

APA Group will invest approximately $1.015 billion for an 80% stake in a new 400MW gas peaking plant in Queensland, backed by a 25-year inflation-linked hedge with CS Energy. The Brigalow project is targeted for completion in early 2029 and expands APA’s contracted power generation portfolio.

AnteoTech has set sales conversion as its FY2027 priority after FY2026 sales revenue slipped to A$460,397, while operating expenses fell sharply and cash stood at A$11.2 million. The battery materials and life sciences company says customer evaluations and partnership discussions are building, but most opportunities remain short of recurring commercial revenue.

Acrow Limited (ASX: ACF) is targeting a sharp FY27 earnings lift after industrial access revenue exceeded $200 million and post-year-end acquisitions expanded its platform. The FY26 result was more mixed: revenue reached a record $336 million, but underlying net profit fell 20% and the dividend was reduced.

HealthCo Healthcare and Wellness REIT (ASX: HCW) reported a $49.7 million FY26 statutory loss, suspended distributions and received an unmodified audit opinion that nevertheless highlighted a material uncertainty over its ability to continue as a going concern. The key unresolved issue is the transfer of 10 Healthscope hospitals to alternative operators.

Sonic Healthcare delivered a strong FY2026, with underlying net profit up 17% to A$621 million and dividends rising to A$1.08 per share. The next test is whether US efficiencies, LADR synergies and organic growth can offset Swiss fee cuts, a delayed UK contract ramp-up and heavier investment demands.

The Queensland Government has deferred the planned 90-day suspension of The Star Gold Coast’s casino licence until 31 March 2027. The reprieve comes with continued independent oversight and a clear warning that key remediation work remains unfinished.

Centuria Office REIT delivered a $55.2 million statutory profit in FY26 and near-record leasing, but its FY27 distribution guidance falls below this year’s payout. The balance sheet is stronger after a $1 billion refinancing, leaving occupancy and rental growth as the key tests ahead.

Basin Energy has begun preliminary leachability and XRD studies at its Newmans rare earth discovery, with follow-up drilling assays due imminently. The early-stage program adds a recoverability test to a project already showing a 3.3 km mineralised corridor in northwest Queensland.

Abacus Group will sell its entire 19.60% interest in Storage King Group for $284.8 million, using the proceeds to repay debt and reduce gearing to about 30%. The transaction simplifies the group’s structure, but part of the sale still requires securityholder approval.